Ecklonia cava, a brown seaweed, is rich in phlorotannins, which inhibit pro-inflammatory cytokines (e.g., TNF-α, IL-6) and COX-2 enzymes, reducing inflammation at the cellular level. Clinical studies show Seanol® significantly reduces oxidative stress and inflammation in musculoskeletal tissues, comparable to NSAIDs but without gastrointestinal side effects. Research on menthol (often paired with Seanol in creams) confirms its vasodilatory effects, increasing blood flow to soothe muscle pain.

Ecklonia cava’s phlorotannins scavenge free radicals, protecting cells from oxidative damage. In vitro studies demonstrate its ability to enhance collagen synthesis and tissue repair. Research on marine polyphenols shows they accelerate wound healing by upregulating growth factors like TGF-β.

Linseed oil (a common co-ingredient) contains omega-3 fatty acids (35–65% linolenic acid), which restore skin lipids and reduce transepidermal water loss. Glycerin in the formulation boosts hydration by binding water to the skin’s deeper layers, with studies showing it outperforms hyaluronic acid in humectancy.

Topical creams with anti-inflammatory botanicals (like Seanol) reduce delayed-onset muscle soreness (DOMS) by modulating inflammation post-exercise. Menthol’s cooling effect (via TRPM8 receptor activation) reduces intramuscular temperature, mimicking ice therapy but with prolonged vasodilation benefits.

Seanol® is FDA-approved and backed by international patents, with studies confirming no adverse effects at recommended doses. Phenoxyethanol (a preservative used in variants) is thermally stable and non-irritating at low concentrations, per safety assessments.